Zydus Cadila receives tentative USFDA approval for Linagliptin Tablets
Linagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor to improve glycemic control in adults with Type 2 diabetes mellitus
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Linagliptin tablets
Zydus Cadila gets tentative USFDA nod for empagliflozin and linagliptin tablets
They are oral diabetes medicines that help control blood sugar levels
Alembic Pharma gets tentative nod from USFDA for Empagliflozin and Linagliptin tablets
Empagliflozin and Linagliptin tablet is indicated as an adjunct to diet and exercise to improve glycemic control in adults with…